Equities Research Analysts' Upgrades for April 17th (ABUS, AROC, AVA, BMI, CCEP, CVU, DXPE, GKOS, KW, LOB)
upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Arbutus Biopharma and Archrock were both upgraded by separate research analysts on Monday.
Equities Research Analysts’ upgrades for Monday, April 17, 2019:
From a Hold rating to a Buy rating.
From a sell to a Hold rating.
From a Hold rating to a Buy rating.
From a Buy rating to a Strong-Buy rating
From a Buy rating to a Strong-Buy rating
From a Buy rating to a Strong-Buy rating
From a sell to a Hold rating.
From a sell to a Hold rating.
To a sell rating.
From a Buy rating to a Strong-Buy rating
From a Buy rating to a Strong-Buy rating
From a Hold rating to a Buy rating.
From a Hold rating to a Buy rating.
From a Hold rating to a Buy rating.
From a Buy rating to a Strong-Buy rating
MarketBeat.com offers a FREE daily email newsletter
.